[Where do SERMs stand in the light of clinical application?].
Takeuchi
Yasuhiro
Y
Toranomon Hospital Endocrine Center.
D001667:Binding, Competitive; D001943:Breast Neoplasms / Q000517:prevention & control; D015195:Drug Design; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D010349:Patient Compliance; D020849:Raloxifene Hydrochloride / Q000378:metabolism / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D011960:Receptors, Estrogen / Q000378:metabolism; D020845:Selective Estrogen Receptor Modulators / Q000378:metabolism / Q000627:therapeutic use*
D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride